论文部分内容阅读
目的:探讨偏头痛应用“黛力新+西比灵”的疗效。方法:抽取我院2014年3月至12月接收的偏头痛患者,共计84例,来作为本次研究的主要对象。采取随机数字分表法,将84例患者等分成研究组与对照组。前者行“黛力新+西比灵”治疗,后者单用西比灵。剖析两组疗效,并行对比。结果:用药后,研究组总有效率97.62%,明显高于对照组78.57%。两组对比,差异具有统计学意义(P<0.05)。研究组的头痛程度,明显轻于对照组。两组对比,差异具有统计学意义(P<0.05)。结论:将黛力新与西比灵进行合理联用,并将其用于偏头痛中,可帮助患者缓解头痛,降低发作频率,缩短头痛持续的时间。
Objective: To investigate the effect of applying migraine on “Detox + Sibirine”. Methods: A total of 84 migraine patients were recruited from March 2014 to December 2014 in our hospital as the main subjects of this study. To take a random number table method, the 84 patients were equally divided into study group and control group. The former line “Detox + xibi Ling ” treatment, the latter single xibingling. Analysis of two groups of efficacy, parallel comparison. Results: After treatment, the total effective rate was 97.62% in the study group, which was significantly higher than 78.57% in the control group. The difference between the two groups was statistically significant (P <0.05). Headache in the study group was significantly lower than that in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: The combination of Deanxit and Sibelium for rational use, and its use in migraine, can help patients relieve headache, reduce the frequency of attacks, shorten the duration of headache.